ICMJE Form for Disclosure of Potential Conflicts of Interest

Similar documents
ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Uniform Disclosure Form for Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

INTERNATIONAL COMMITTEE 9/ MEDICAL [OURNAL EDITORS

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

All authors of papers submitted to (name of journal) must complete this form and disclose any real or perceived conflict of interest.

IeMJE~iA~~1~1 J~~~~tl'~g;;'g'~

UA Policy on Conflict of Interest/Financial Disclosure in Research and Other Sponsored Programs (revised August 2012) FREQUENTLY ASKED QUESTIONS

Financial Conflicts of Interest in Research: Putting the Pieces Together

UC Davis Policy and Procedure Manual

Conflict of Interest with Grants Policy DRAFT

CALIFORNIA STATE UNIVERSITY LOS ANGELES. for PROJECTS FUNDED BY THE PUBLIC HEALTH SERVICE (PHS)

Financial Conflict of Interest Promoting Objectivity in Research Policy

Letter of Intent to Establish a Consortium Agreement Saint Louis University as Primary Applicant

Conflict of Interest Management Plan. You disclosed one or more significant financial interest(s) related to your university responsibilities.

Section 1 Conflicts of Interest Introduction

Please scroll through and complete the entire form! Your application will not be accepted if all areas highlighted in yellow are not complete.

XAVIER UNIVERSITY. Financial Conflict of Interest Policy-Federal Grant Proposals

Investigator s Disclosure of Economic Interests Addendum

Florida International University Herbert Wertheim College of Medicine Industry Relations Policy and Guidelines 2/16/15

FINANCIAL CONFLICT OF INTEREST POLICY Public Health Services SECTION 1 OVERVIEW, APPLICABILITY AND RESPONSIBILITIES

RESEARCH CONFLICT OF INTEREST. Vyju Ram, MD Conflict of Interest Program

MARICOPA COUNTY COMMUNITY COLLEGE DISTRICT STANDARDS FOR FINANCIAL DISCLOSURE TO AVOID CONFLICT OF INTEREST IN FEDERALLY-FUNDED PROJECTS

POLICY: Conflict of Interest

2 nd Annual MedStar Washington Hospital Center Nursing Evidence-Based-Practice & Research Conference

UTAH VALLEY UNIVERSITY Policies and Procedures

ALLEGHENY GENERAL HOSPITAL Pittsburgh, Pennsylvania

ecoi Fast Start Guide

SEATTLE CHILDREN S RESEARCH INSTITUTE OPERATING POLICIES / PROCEDURES

Grant Administration Glossary of Commonly-Used Terms in Sponsored Programs

2014 Breast Cancer Symposium September 4 6, 2014 San Francisco, CA

Your role in the CME Activity: Presenter Author Planning Committee Moderator Program Director. Title of CME Activity: Activity Date:

Financial Conflict of Interest Training

Approved by: UMMG Executive Committee. Date Approved: NOVEMBER 22, 2011

ACCME Data Request Form 792_ Page 1 of 8

1. Employment, Consulting, Product Development (Design Team/Royalty-based Contracts) and Research Arrangements with a Commercial Orthopaedic Company

American Head & Neck Society

Intellectual Property Policy: Purpose. Applicability. Definitions

Conflict of Interest/Commitment

NOVA SOUTHEASTERN UNIVERSITY OFFICE OF SPONSORED PROGRAMS POLICIES AND PROCEDURES

GUIDELINES FOR INTERACTIONS OF CLINICIANS AND RESEARCHERS WITH INDUSTRY

NAMI Illinois 2010 Annual Conference

Financial Conflict of Interest Policy

Two Submission Dates. January 4, 2018 June 28, 2018

Educational Grant Application

UMass Memorial Medical Center Policy 1143 Vendor Relationships

Request to Use an External IRB as an IRB of Record

Standard Operating Procedures for P209: Investigator Conflict of Interest Policy

Collaborative Operations and Services Grant Program GUIDELINES Revised January 15, 2014

Charles A. King Trust Postdoctoral Research Fellowship Program

Conflict of Interest Policy Texas Lutheran University

Dear Prospective Presenter:

Authorized licensed use limited to: UNIVERSITA MODENA. Downloaded on November 10,2011 at 14:46:47 UTC from IEEE Xplore. Restrictions apply.

EMSC Emergency Medical Services Corporation EMSC Policies and Procedures Charitable Contribution Policy Policy No 203

> TITLE 13. LAW AND PUBLIC SAFETY

CME Policies & Procedures

Physician/Industry Contacts: Updated Focus on CME & Grassley Looks at Possible Research Conflicts

Research and Development (R&D) tax credit

Investigator Conflict of Interest Disclosure Policy for Human Subjects Research

TRIOLOGICAL SOCIETY AUTHOR FORM

Financial Conflict of Interest: Investigator Procedures. Office of Research, Innovation, and Economic Development Research Integrity and Compliance

European Respiratory Society Annual Declaration of Interest 2016

Children s Discovery Institute Grants Policies

SANTA RITA CARE CENTER Notice of Information Practices

St. Elizabeth Healthcare- Financial Assistance Policy

TEXAS SOCIETY OF PSYCHIATRIC PHYSICIANS CME ACTIVITY DEVELOPMENT WORKSHEET

University of Ottawa (uottawa) Terms & Non-Disclosure Agreement. for. Mitacs Accelerate Internships and. Mitacs Elevate Postdoctoral Fellowships

9 th National Conference on Cancer Nursing Research February 8 10, 2007 Hollywood, California. General Information

BUILDING YOUR TOOLBOX TO MANAGE CONFLICT OF INTEREST: SUNSHINE, OPEN PAYMENTS, AND INVESTIGATIONS

SECTION PROPOSAL FOR EDUCATION ACTIVITY:

Guidelines & Application for Conducting Special Events, Benefits or Promotions to Benefit The Los Angeles County Affiliate of Susan G.

If there are any unanswered (Required) questions by the deadline, your LOI will be disqualified and rejected from the Challenge.

Compliance Program And Code of Conduct. United Regional Health Care System

FREQUENTLY ASKED QUESTIONS

LETTER OF AGREEMENT TERMS AND CONDITIONS OF DISCRETIONARY GRANT

27th Annual Holiday Knee and Hip Course December 3-5, 2015 The Grand Hyatt New York City, NY

TECHNOLOGY DEVELOPMENT PROGRAM

LETTER OF INTENT INSTRUCTIONS

CANCER COUNCIL NSW PROGRAM GRANTS PEER REVIEW GUIDELINES

Guiding Principle... 2

Medicolegal Aspects of Marihuana for Medical Purposes

PATIENT REGISTRATION FORM (ecw)

The University of Utah

education continuing CARRELL-KRUSEN NEUROMUSCULAR SYMPOSIUM 33 rd ANNUAL Thursday-Friday, February 17-18, 2011

ASSOCIATION FOR ACCESSIBLE MEDICINES Code of Business Ethics. March 2018

City of Colville Vinson Fund Application

Damon Runyon-Sohn Pediatric Cancer Fellowship Award Award Statement

SENATE SUBSTITUTE FOR. SENATE, No. 787 STATE OF NEW JERSEY. 213th LEGISLATURE ADOPTED MARCH 17, 2008

STANDARDS OF CONDUCT A MESSAGE FROM THE CHANCELLOR INTRODUCTION COMPLIANCE WITH THE LAW RESEARCH AND SCIENTIFIC INTEGRITY CONFLICTS OF INTEREST

Transcription:

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. 1. 2. 3. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. 4. 5. Intellectual Property. This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties. Relationships not covered above. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Ayanian Definitions. Entity: government agency, foundation, commercial sponsor, academic institution, etc. Grant: A grant from an entity, generally [but not always] paid to your organization Personal Fees: Monies paid to you for services rendered, generally honoraria, royalties, or fees for consulting, lectures, speakers bureaus, expert testimony, employment, or other affiliations Non-Financial Support: Examples include drugs/equipment supplied by the entity, travel paid by the entity, writing assistance, administrative support, etc. Other: Anything not covered under the previous three boxes Pending: The patent has been filed but not issued Issued: The patent has been issued by the agency Licensed: The patent has been licensed to an entity, whether earning royalties or not Royalties: Funds are coming in to you or your institution due to your patent 1

Section 1. Identifying Information 1. Given Name (First Name) John 2. Surname (Last Name) Ayanian 3. Date 18-May-2018 4. Are you the corresponding author? Yes No 5. Manuscript Title Mitigating the Risks of Medicaid Work Requirements 6. Manuscript Identifying Number (if you know it) 18-06129 Section 2. The Work Under Consideration for Publication Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc.)? Are there any relevant conflicts of interest? Yes No Section 3. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication. Are there any relevant conflicts of interest? Yes No If yes, please fill out the appropriate information below. Name of Entity Grant? Personal Fees? Non-Financial Support? Other? Comments Michigan Department of Health and Human Services Section 4. Intellectual Property -- Patents & Copyrights Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes No Ayanian 2

Section 5. Relationships not covered above Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Yes, the following relationships/conditions/circumstances are present (explain below): No other relationships/conditions/circumstances that present a potential conflict of interest At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Section 6. Disclosure Statement Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box below. Dr. Ayanian reports grants from Michigan Department of Health and Human Services outside the submitted work. Evaluation and Feedback Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form. Ayanian 3

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. 1. 2. 3. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. 4. 5. Intellectual Property. This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties. Relationships not covered above. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Definitions. Entity: government agency, foundation, commercial sponsor, academic institution, etc. Grant: A grant from an entity, generally [but not always] paid to your organization Personal Fees: Monies paid to you for services rendered, generally honoraria, royalties, or fees for consulting, lectures, speakers bureaus, expert testimony, employment, or other affiliations Non-Financial Support: Examples include drugs/equipment supplied by the entity, travel paid by the entity, writing assistance, administrative support, etc. Other: Anything not covered under the previous three boxes Pending: The patent has been filed but not issued Issued: The patent has been issued by the agency Licensed: The patent has been licensed to an entity, whether earning royalties or not Royalties: Funds are coming in to you or your institution due to your patent Goold 1

Section 1. Identifying Information 1. Given Name (First Name) Susan 2. Surname (Last Name) Goold 3. Date 17-May-2018 4. Are you the corresponding author? Yes No Corresponding Author s Name John Z. Ayanian 5. Manuscript Title Mitigating the Risks of Medicaid Work Requirements 6. Manuscript Identifying Number (if you know it) 18-06129 Section 2. The Work Under Consideration for Publication Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc.)? Are there any relevant conflicts of interest? Yes No Section 3. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication. Are there any relevant conflicts of interest? Yes No If yes, please fill out the appropriate information below. Name of Entity Grant? Personal Fees? Non-Financial Support? Other? Comments Michigan Department of Health and Human Services Section 4. Intellectual Property -- Patents & Copyrights Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes No Goold 2

Section 5. Relationships not covered above Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Yes, the following relationships/conditions/circumstances are present (explain below): No other relationships/conditions/circumstances that present a potential conflict of interest At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Section 6. Disclosure Statement Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box below. Dr. Goold reports grants from Michigan Department of Health and Human Services outside the submitted work. Evaluation and Feedback Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form. Goold 3

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. 1. 2. 3. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company. 4. 5. Intellectual Property. This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties. Relationships not covered above. Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. Tipirneni Definitions. Entity: government agency, foundation, commercial sponsor, academic institution, etc. Grant: A grant from an entity, generally [but not always] paid to your organization Personal Fees: Monies paid to you for services rendered, generally honoraria, royalties, or fees for consulting, lectures, speakers bureaus, expert testimony, employment, or other affiliations Non-Financial Support: Examples include drugs/equipment supplied by the entity, travel paid by the entity, writing assistance, administrative support, etc. Other: Anything not covered under the previous three boxes Pending: The patent has been filed but not issued Issued: The patent has been issued by the agency Licensed: The patent has been licensed to an entity, whether earning royalties or not Royalties: Funds are coming in to you or your institution due to your patent 1

Section 1. Identifying Information 1. Given Name (First Name) Renuka 2. Surname (Last Name) Tipirneni 3. Date 16-May-2018 4. Are you the corresponding author? Yes No Corresponding Author s Name John Z. Ayanian 5. Manuscript Title Mitigating the Risks of Medicaid Work Requirements 6. Manuscript Identifying Number (if you know it) 18-06129 Section 2. The Work Under Consideration for Publication Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc.)? Are there any relevant conflicts of interest? Yes No Section 3. Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication. Are there any relevant conflicts of interest? Yes No If yes, please fill out the appropriate information below. Name of Entity Grant? Personal Fees? Non-Financial Support? Other? Comments Michigan Department of Health and Human Services Contract for evaluation of Michigan's Medicaid expansion program, the Healthy Michigan Plan Section 4. Intellectual Property -- Patents & Copyrights Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes No Tipirneni 2

Section 5. Relationships not covered above Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work? Yes, the following relationships/conditions/circumstances are present (explain below): No other relationships/conditions/circumstances that present a potential conflict of interest At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements. On occasion, journals may ask authors to disclose further information about reported relationships. Section 6. Disclosure Statement Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box below. Dr. Tipirneni reports grants from Michigan Department of Health and Human Services outside the submitted work. Evaluation and Feedback Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form. Tipirneni 3